Rhein targets macrophage SIRT2 to promote adipose tissue thermogenesis in obesity in mice
Rattachement africain : cn, us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Rhein, a component derived from rhubarb, has been proven to possess anti-inflammatory properties. Here, we show that rhein mitigates obesity by promoting adipose tissue thermogenesis in diet-induced obese mice. We construct a macrophage-adipocyte co-culture system and demonstrate that rhein promotes adipocyte thermogenesis through inhibiting NLRP3 inflammasome activation in macrophages. Moreover, clues from acetylome analysis identify SIRT2 as a potential drug target of rhein. We further verify that rhein directly interacts with SIRT2 and inhibits NLRP3 inflammasome activation in a SIRT2-dependent way. Myeloid knockdown of SIRT2 abrogates adipose tissue thermogenesis and metabolic benefits in obese mice induced by rhein. Together, our findings elucidate that rhein inhibits NLRP3 inflammasome activation in macrophages by regulating SIRT2, and thus promotes white adipose tissue thermogenesis during obesity. These findings uncover the molecular mechanism underlying the anti-inflammatory and anti-obesity effects of rhein, and suggest that rhein may become a potential drug for treating obesity. Zhou et al. reveal that rhein improves adipose tissue thermogenesis via suppressing the NLRP3 inflammasome in macrophages during obesity. They further identify that rhein directly binds to SIRT2 and inhibits NLRP3 inflammasome by activating SIRT2.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Rhein targets macrophage SIRT2 to promote adipose tissue thermogenesis in obesity in mice
- Date Crossref
- 16/08/2024
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Nanjing University of Chinese Medicine Department of Endocrinology pays non établi dans la noticeUniversité ou école supérieure
-
Jiangsu Province Hospital pays non établi dans la noticeÉtablissement de santé
-
University of California Department of Medicine pays non établi dans la noticeUniversité ou école supérieure
Department of Endocrinology — Nanjing University of Chinese Medicine, Jiangsu Province Hospital et Department of Medicine — University of California.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.